SG11201807487WA - Generation of midbrain-specific organoids from human pluripotent stem cells - Google Patents

Generation of midbrain-specific organoids from human pluripotent stem cells

Info

Publication number
SG11201807487WA
SG11201807487WA SG11201807487WA SG11201807487WA SG11201807487WA SG 11201807487W A SG11201807487W A SG 11201807487WA SG 11201807487W A SG11201807487W A SG 11201807487WA SG 11201807487W A SG11201807487W A SG 11201807487WA SG 11201807487W A SG11201807487W A SG 11201807487WA
Authority
SG
Singapore
Prior art keywords
midbrain
singapore
international
deriving
tissues
Prior art date
Application number
SG11201807487WA
Other languages
English (en)
Inventor
Junghyun Jo
Huck Hui Ng
Hyunsoo Shawn Je
Original Assignee
Agency Science Tech & Res
Nat Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res, Nat Univ Singapore filed Critical Agency Science Tech & Res
Publication of SG11201807487WA publication Critical patent/SG11201807487WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/72—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/76—Agarose, agar-agar
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/78—Cellulose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG11201807487WA 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells SG11201807487WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201601965P 2016-03-14
PCT/SG2017/050126 WO2017160234A1 (fr) 2016-03-14 2017-03-14 Génération d'organoïdes spécifiques du mésencéphale à partir de cellules souches pluripotentes humaines

Publications (1)

Publication Number Publication Date
SG11201807487WA true SG11201807487WA (en) 2018-09-27

Family

ID=59851957

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201807487WA SG11201807487WA (en) 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells
SG10201913687VA SG10201913687VA (en) 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201913687VA SG10201913687VA (en) 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells

Country Status (5)

Country Link
US (1) US20190169576A1 (fr)
EP (1) EP3430132A4 (fr)
CN (1) CN109996870A (fr)
SG (2) SG11201807487WA (fr)
WO (1) WO2017160234A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9719068B2 (en) 2010-05-06 2017-08-01 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
US10174289B2 (en) 2014-05-28 2019-01-08 Children's Hospital Medical Center Methods and systems for converting precursor cells into gastric tissues through directed differentiation
WO2016061464A1 (fr) 2014-10-17 2016-04-21 Children's Hospital Center, D/B/A Cincinnati Children's Hospital Medical Center Modèle in vivo d'intestin grêle humain faisant intervenir des cellules souches pluripotentes et ses procédés de fabrication et d'utilisation
US11066650B2 (en) 2016-05-05 2021-07-20 Children's Hospital Medical Center Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same
US10583286B2 (en) * 2016-08-23 2020-03-10 Boston Scientific Neuromodulation Corporation Methods and devices for neuromodulation of the adrenal gland
AU2017373767B2 (en) 2016-12-05 2021-09-16 Children's Hospital Medical Center Colonic organoids and methods of making and using same
CN108456659B (zh) * 2018-03-14 2020-05-05 浙江霍德生物工程有限公司 3d大脑类器官的制备方法
CN110295145B (zh) * 2018-03-22 2020-10-16 苏州麦迪耐斯医药科技有限公司 一种体外培养脑肿瘤细胞的培养液及培养方法
AU2019340838A1 (en) * 2018-09-11 2021-03-25 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Automated generation and analysis of organoids
CN112996906A (zh) * 2018-11-15 2021-06-18 Jsr株式会社 脑类器官的制造方法
CA3129656A1 (fr) * 2019-02-11 2020-08-20 Miltenyi Biotec B.V. & Co. KG Generation de structures de tissu artificiel derivees de cellules souches pluripotentes humaines sans matrices tridimensionnelles
JP7366332B2 (ja) * 2019-06-05 2023-10-23 公立大学法人奈良県立医科大学 脳幹オルガノイドの作製方法
CN114026222A (zh) * 2019-07-05 2022-02-08 学校法人庆应义塾 脑类器官的制造方法
KR102228400B1 (ko) * 2019-09-24 2021-03-16 고려대학교 산학협력단 뇌 오가노이드 제조 방법
US20220389378A1 (en) * 2019-11-22 2022-12-08 Novo Nordisk A/S Spin-aggregated neural microspheres and the application thereof
JP2023512453A (ja) * 2020-01-13 2023-03-27 アスペン ニューロサイエンス インコーポレイテッド 神経細胞を分化させる方法ならびに関連する組成物および使用方法
WO2021216623A1 (fr) * 2020-04-21 2021-10-28 Aspen Neuroscience, Inc. Édition génique de lrrk2 dans des cellules souches et procédé d'utilisation de cellules différenciées à partir de celles-ci
WO2021216622A1 (fr) * 2020-04-21 2021-10-28 Aspen Neuroscience, Inc. Édition génique de gba1 dans des cellules souches et procédé d'utilisation de cellules différenciées à partir de celles-ci
WO2021232234A1 (fr) * 2020-05-19 2021-11-25 武汉睿健医药科技有限公司 Procédé d'induction sans sérum pour cellule neuronale sensorielle
WO2021251820A1 (fr) * 2020-06-08 2021-12-16 Technische Universiteit Eindhoven Procédés de production d'un tissu neuronal (tridimensionnel)
KR102346243B1 (ko) * 2020-06-29 2022-01-04 주식회사 오간팩토리 중뇌 오가노이드, 이의 고속 및 대량 제조 방법, 이를 이용한 신경독성물질 스크리닝 방법 및 도파민성 신경세포 관련 질환 치료제 스크리닝 방법
CN115885037A (zh) * 2020-06-29 2023-03-31 广东省奥干诺伊德生物科技有限公司 中脑类器官及其高速大规模制造方法、利用它筛选神经毒性物质和筛选多巴胺能神经元相关疾病药物的方法
EP3992280A1 (fr) * 2020-10-30 2022-05-04 Kugelmeiers Ltd. Procédé de génération de neurosphères
CN114736864B (zh) * 2020-12-23 2024-01-26 武汉睿健医药科技有限公司 一种神经干细胞诱导分化培养基及诱导分化方法
CN113046309B (zh) * 2021-03-26 2023-05-05 成都云测医学生物技术有限公司 悬浮培养脑类器官的培养基及其应用
CN113249319B (zh) * 2021-05-19 2022-11-11 北京大学 一种脑脊液类器官的培养基及其培养方法
CN113789301B (zh) * 2021-08-27 2022-05-10 广州瑞臻再生医学科技有限公司 一种制备高纯度的诱导性多能干细胞来源的人脑多巴胺能神经元的方法
CN113493768B (zh) * 2021-09-06 2021-12-24 中国科学院动物研究所 神经类器官及其制备方法
KR20230081737A (ko) * 2021-11-29 2023-06-08 주식회사 오간팩토리 간 오가노이드, 이의 고속 및 대량 제조 방법, 이를 이용한 약물의 효능 및 독성 스크리닝 방법
WO2023137200A2 (fr) * 2022-01-13 2023-07-20 The Board Of Trustees Of The Leland Stanford Junior University Génération d'organoïdes d'organisateur neuronal et d'assembloïdes de ligne médiane à partir de cellules souches pluripotentes humaines
CN115404218A (zh) * 2022-01-13 2022-11-29 南华大学附属第一医院 一种包含胶质细胞的3d人脑类器官培养方法
WO2023201046A1 (fr) * 2022-04-14 2023-10-19 Lieber Institute, Inc. Compositions et méthode de traitement d'une dystonie-parkinsonisme liée à l'x
EP4286513A1 (fr) 2022-06-03 2023-12-06 IMBA-Institut für Molekulare Biotechnologie GmbH Fusion de culture de tissus triple
WO2024017538A1 (fr) * 2022-07-19 2024-01-25 Medizinische Hochschule Hannover Procédé de production d'organoïdes à partir de cellules de mammifère
EP4310177A1 (fr) * 2022-07-19 2024-01-24 Medizinische Hochschule Hannover Procédé de production d'organoïdes à partir de cellules de mammifères
CN115044539A (zh) * 2022-08-16 2022-09-13 中义(北京)健康研究院 一种鲨鱼肝细胞及其培养方法
CN117778313B (zh) * 2024-02-23 2024-05-24 成都云测医学生物技术有限公司 脑类器官获得间充质干细胞分化方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111244D0 (en) * 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
MX368315B (es) * 2012-04-24 2019-09-27 Int Stem Cell Corporation Derivación de células madre neurales y neuronas dopaminérgicas a partir de células madre pluripotentes humanas.
EP2743345A1 (fr) * 2012-12-13 2014-06-18 IMBA-Institut für Molekulare Biotechnologie GmbH Culture de tissu différencié hétérogène tridimensionnel
KR101696874B1 (ko) * 2013-07-31 2017-01-16 한국생명공학연구원 직접 리프로그래밍을 통한 유도 도파민성 전구세포 제조방법
DE102014003465A1 (de) * 2014-03-11 2015-09-17 NeuroProof GmbH Gewinnung von Gehirnregion-spezifischen neuronalen Kulturen aus dreidimensionalen Gewebekulturen von Stammzellen
WO2015143342A1 (fr) * 2014-03-21 2015-09-24 Cellular Dynamics International, Inc. Production de neurones dopaminergiques du mésencéphale et méthodes d'utilisation associées
CN107427537A (zh) * 2015-03-03 2017-12-01 哈佛学院院长及董事 产生功能性人体组织的方法
LU92845B1 (en) * 2015-10-08 2017-05-02 Univ Du Luxembourg Campus Belval Means and methods for generating midbrain organoids
EP3190176A1 (fr) * 2016-01-11 2017-07-12 IMBA-Institut für Molekulare Biotechnologie GmbH Procédé de développement de culture tissulaire sur échafaudage et culture de tissus différenciés

Also Published As

Publication number Publication date
US20190169576A1 (en) 2019-06-06
WO2017160234A1 (fr) 2017-09-21
EP3430132A4 (fr) 2019-12-25
CN109996870A (zh) 2019-07-09
EP3430132A1 (fr) 2019-01-23
SG10201913687VA (en) 2020-03-30

Similar Documents

Publication Publication Date Title
SG11201807487WA (en) Generation of midbrain-specific organoids from human pluripotent stem cells
SG11201901747VA (en) Inhibitors of cellular metabolic processes
SG11201407486PA (en) Compositions and methods for modulating utrn expression
SG11201901628XA (en) Methods and compositions for spinal cord cells
SG11201806745RA (en) Sulfonylureas and related compounds and use of same
SG11201903155XA (en) Pharmaceutical compounds
SG11201805300QA (en) Heterocyclic compounds as immunomodulators
SG11201804363UA (en) Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
SG11201805835WA (en) Modified oncolytic virus
SG11201809064QA (en) Chimeric neurotoxins
SG11201805044WA (en) Compounds useful as kinase inhibitors
SG11201807720TA (en) Methods and systems for determining antibiotic susceptibility
SG11201804710TA (en) Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof
SG11201406903SA (en) Cell culture compositions and methods for polypeptide production
SG11201407483YA (en) Compositions and methods for modulating smn gene family expression
SG11201903032SA (en) Methods and compositions related to nk cell and anti-pdl1 cancer therapies
SG11201906959RA (en) Aryl hydrocarbon receptor (ahr) modulator compounds
SG11201810471YA (en) T cell expansion
SG11201908472VA (en) Compositions and methods for activating nk cells
SG11201900058YA (en) Method of generating mesenchymal stem cells and uses thereof
SG11201909501TA (en) Personalized 3d neural culture system for generating human oligodendrocytes and studying myelination in vitro
SG11201900361RA (en) Methods of treating prostate cancer
SG11201408808WA (en) Method and system for treatment of biological tissue
SG11201909602TA (en) Compositions and methods involving probiotic molecules
SG11201906225PA (en) Maintenance and expansion of pancreatic progenitor cells